Literature DB >> 24290911

Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

Kristi Baker1, Timo Rath1, Magdalena B Flak1, Janelle C Arthur2, Zhangguo Chen1, Jonathan N Glickman3, Inti Zlobec4, Eva Karamitopoulou4, Matthew D Stachler5, Robert D Odze5, Wayne I Lencer6, Christian Jobin7, Richard S Blumberg8.   

Abstract

Cancers arising in mucosal tissues account for a disproportionately large fraction of malignancies. Immunoglobulin G (IgG) and the neonatal Fc receptor for IgG (FcRn) have an important function in the mucosal immune system that we have now shown extends to the induction of CD8(+) T cell-mediated antitumor immunity. We demonstrate that FcRn within dendritic cells (DCs) was critical for homeostatic activation of mucosal CD8(+) T cells that drove protection against the development of colorectal cancers and lung metastases. FcRn-mediated tumor protection was driven by DCs activation of endogenous tumor-reactive CD8(+) T cells via the cross-presentation of IgG complexed antigens (IgG IC), as well as the induction of cytotoxicity-promoting cytokine secretion, particularly interleukin-12, both of which were independently triggered by the FcRn-IgG IC interaction in murine and human DCs. FcRn thus has a primary role within mucosal tissues in activating local immune responses that are critical for priming efficient anti-tumor immunosurveillance.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24290911      PMCID: PMC3902970          DOI: 10.1016/j.immuni.2013.11.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  55 in total

1.  Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor.

Authors:  Steven M Claypool; Bonny L Dickinson; Jessica S Wagner; Finn-Eirik Johansen; Nanda Venu; Jason A Borawski; Wayne I Lencer; Richard S Blumberg
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

2.  Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.

Authors:  F Brichory; D Beer; F Le Naour; T Giordano; S Hanash
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

3.  The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs.

Authors:  Derry C Roopenian; Gregory J Christianson; Thomas J Sproule; Aaron C Brown; Shreeram Akilesh; Nadja Jung; Stefka Petkova; Lia Avanessian; Eun Young Choi; Daniel J Shaffer; Peter A Eden; Clark L Anderson
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

4.  Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells.

Authors:  Masaru Yoshida; Steven M Claypool; Jessica S Wagner; Emiko Mizoguchi; Atsushi Mizoguchi; Derry C Roopenian; Wayne I Lencer; Richard S Blumberg
Journal:  Immunity       Date:  2004-06       Impact factor: 31.745

Review 5.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

6.  Ulcerative colitis specific cytotoxic IgG-autoantibodies against colonic epithelial cancer cells.

Authors:  I O Auer; L Grosch; C Hardörfer; A Röder
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

7.  Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.

Authors:  Koji Aoki; Yoshitaka Tamai; Shigeo Horiike; Masanobu Oshima; Makoto M Taketo
Journal:  Nat Genet       Date:  2003-11-16       Impact factor: 38.330

8.  MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells.

Authors:  X Zhu; G Meng; B L Dickinson; X Li; E Mizoguchi; L Miao; Y Wang; C Robert; B Wu; P D Smith; W I Lencer; R S Blumberg
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

9.  Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung.

Authors:  Gerburg M Spiekermann; Patricia W Finn; E Sally Ward; Jennifer Dumont; Bonny L Dickinson; Richard S Blumberg; Wayne I Lencer
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

10.  Immunoglobulins associated with human tumours in vivo: IgG concentrations in eluates of colonic carcinomas.

Authors:  J M MacSween; S L Eastwood
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

View more
  56 in total

1.  Distribution of FcRn Across Species and Tissues.

Authors:  Sari Latvala; Bjoern Jacobsen; Michael B Otteneder; Annika Herrmann; Sven Kronenberg
Journal:  J Histochem Cytochem       Date:  2017-04-12       Impact factor: 2.479

Review 2.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

Review 3.  B cells, plasma cells and antibody repertoires in the tumour microenvironment.

Authors:  George V Sharonov; Ekaterina O Serebrovskaya; Diana V Yuzhakova; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Rev Immunol       Date:  2020-01-27       Impact factor: 53.106

Review 4.  Intratumoral dendritic cells in the anti-tumor immune response.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2015-01-19       Impact factor: 11.530

Review 5.  Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Authors:  Mevyn Nizard; Mariana O Diniz; Helene Roussel; Thi Tran; Luis Cs Ferreira; Cecile Badoual; Eric Tartour
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.

Authors:  Sung-Youl Ko; Amarendra Pegu; Rebecca S Rudicell; Zhi-yong Yang; M Gordon Joyce; Xuejun Chen; Keyun Wang; Saran Bao; Thomas D Kraemer; Timo Rath; Ming Zeng; Stephen D Schmidt; John-Paul Todd; Scott R Penzak; Kevin O Saunders; Martha C Nason; Ashley T Haase; Srinivas S Rao; Richard S Blumberg; John R Mascola; Gary J Nabel
Journal:  Nature       Date:  2014-08-13       Impact factor: 49.962

7.  IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses.

Authors:  Barbara Platzer; Kutlu G Elpek; Viviana Cremasco; Kristi Baker; Madeleine M Stout; Cornelia Schultz; Eleonora Dehlink; Kai-Ting C Shade; Robert M Anthony; Richard S Blumberg; Shannon J Turley; Edda Fiebiger
Journal:  Cell Rep       Date:  2015-03-05       Impact factor: 9.423

Review 8.  Trial watch: Dendritic cell-based anticancer therapy.

Authors:  Norma Bloy; Jonathan Pol; Fernando Aranda; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fučíková; Jérôme Galon; Eric Tartour; Radek Spisek; Madhav V Dhodapkar; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

Review 9.  Targeting FcRn for the modulation of antibody dynamics.

Authors:  E Sally Ward; Siva Charan Devanaboyina; Raimund J Ober
Journal:  Mol Immunol       Date:  2015-03-09       Impact factor: 4.407

Review 10.  Immunity, inflammation, and cancer: an eternal fight between good and evil.

Authors:  Shabnam Shalapour; Michael Karin
Journal:  J Clin Invest       Date:  2015-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.